Publicis: U.S.-Wide Settlement Agreement Reached Concerning Opioid- Related Work by Rosetta, Bringing to a Close Three Years of Discussions
Publicis (Paris:PUB):
A comprehensive resolution has been reached with all 50 State Attorneys General, the
The Attorneys General have recognized Publicis Health’s good faith and responsible corporate citizenship in reaching this resolution.
As the former owner of Rosetta, which was shuttered ten years ago,
“After three years of discussions, this settlement brings the matter to a close with a net payment of €148 million. The full settlement amount should quickly and directly contribute to the States’ opioid relief effort.
This settlement, in which the Attorneys General recognized Publicis Health’s ‘good faith and responsible corporate citizenship’, is in no way an admission of wrongdoing or liability. We will, if need be, defend ourselves against any litigation that this agreement does not resolve.
“The work for pharmaceutical companies addressed by this settlement was at all times fully compliant with the law. It was undertaken primarily by Rosetta, a small agency shuttered ten years ago, that was already working with pharmaceutical clients that manufactured opioid medication when it was acquired thirteen years ago in 2011. Its work related to these products was used solely with healthcare providers, not consumers, using communication tools and language expressly approved by the FDA. Rosetta’s role was limited to performing many of the standard advertising services that agencies provide to their clients, for products that are to this day prescribed to patients, covered by major private insurers, Medicare, and authorized by State Pharmacy Boards.
“We recognize the broader context in which that lawful work took place. The fight against the opioid crisis in
**********
About the Financial Effects of this
In the context of this settlement, following the payment of
About
At
For more information, visit us at www.publicishealth.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240201957072/en/
Kekst CNC
Corporate Communications,
kipp.cheng@publicishealth.com
publicishealth@kekstcnc.com
Source: Publicis